Green tea polyphenols prevent aging‐ and estrogen‐deficiency‐induced bone loss in aged and ovariectomized female rats

Chwan Li Shen,Julie Guerrieri,James K Yeh,Jia‐Sheng Wang
DOI: https://doi.org/10.1096/fasebj.21.5.a354-b
2007-04-01
The FASEB Journal
Abstract:Human epidemiological studies and laboratory cellular studies strongly suggested that green tea polyphenols (GTPs), extracted from green tea, are promising agents for preventing bone loss in women due to currently unclear mechanisms. To explore possible mechanisms of beneficial bone health effect of GTPs, effects of GTP on BMD and related mechanism(s) were investigated in aged and OVX female rats. A 2 (sham vs. ovariectomy) × 3 (no GTPs, 0.1% GTPs , and 0.5% GTPs in drinking water) factorial design using 70 aged female rats assigned to 7 groups (n=10/group): initial control (IC), sham control, SHAM+0.1% GTPs, SHAM+0.5% GTPs, OVX control, OVX+0.1% GTPs, and OVX+0.5% GTPs for 16 wks. Ten rats in IC group were euthanized at the beginning of study to provide baseline parameters. OVX groups had greater final body weights than those in SHAM groups. Average consumption of drinking water was the lowest in high GTP concentration groups. GTPs supplementation increased femur BMD, uterus weights, and liver GPX activity in both SHAM and OVX rats at a dose‐dependent manner. There was no difference in femur BMD, uterus weights, and liver glutathione peroxidase between the IC group and the SHAM+0.5% GTPs groups. These data demonstrated that GTPs supplementation mitigates aging‐induced bone loss in aged SHAM rats and aging plus estrogen‐deficiency‐induced bone loss in aged OVX rats. Such a protective role of GTPs may, in part, attribute to an increase of antioxidant capacity. The results suggest a potentially significant prophylactic role of green tea in bone health of premenopausal and postmenopausal women.
What problem does this paper attempt to address?